188 related articles for article (PubMed ID: 18796695)
1. A double-headed cathepsin B inhibitor devoid of warhead.
Schenker P; Alfarano P; Kolb P; Caflisch A; Baici A
Protein Sci; 2008 Dec; 17(12):2145-55. PubMed ID: 18796695
[TBL] [Abstract][Full Text] [Related]
2. Role of the occluding loop in cathepsin B activity.
Illy C; Quraishi O; Wang J; Purisima E; Vernet T; Mort JS
J Biol Chem; 1997 Jan; 272(2):1197-202. PubMed ID: 8995421
[TBL] [Abstract][Full Text] [Related]
3. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
[TBL] [Abstract][Full Text] [Related]
4. The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.
Musil D; Zucic D; Turk D; Engh RA; Mayr I; Huber R; Popovic T; Turk V; Towatari T; Katunuma N
EMBO J; 1991 Sep; 10(9):2321-30. PubMed ID: 1868826
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular matrix degradation and tumour invasion.
Mitrović A; Mirković B; Sosič I; Gobec S; Kos J
Biol Chem; 2016 Jan; 397(2):165-74. PubMed ID: 26565553
[TBL] [Abstract][Full Text] [Related]
6. Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B.
Redzynia I; Ljunggren A; Abrahamson M; Mort JS; Krupa JC; Jaskolski M; Bujacz G
J Biol Chem; 2008 Aug; 283(33):22815-25. PubMed ID: 18515357
[TBL] [Abstract][Full Text] [Related]
7. S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.
Krupa JC; Hasnain S; Nägler DK; Ménard R; Mort JS
Biochem J; 2002 Feb; 361(Pt 3):613-9. PubMed ID: 11802791
[TBL] [Abstract][Full Text] [Related]
8. Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop.
Nycander M; Estrada S; Mort JS; Abrahamson M; Björk I
FEBS Lett; 1998 Jan; 422(1):61-4. PubMed ID: 9475170
[TBL] [Abstract][Full Text] [Related]
9. pH Dependence of inhibitors targeting the occluding loop of cathepsin B.
Cathers BE; Barrett C; Palmer JT; Rydzewski RM
Bioorg Chem; 2002 Aug; 30(4):264-75. PubMed ID: 12392705
[TBL] [Abstract][Full Text] [Related]
10. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts.
Nägler DK; Storer AC; Portaro FC; Carmona E; Juliano L; Ménard R
Biochemistry; 1997 Oct; 36(41):12608-15. PubMed ID: 9376367
[TBL] [Abstract][Full Text] [Related]
11. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
[TBL] [Abstract][Full Text] [Related]
12. Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft.
Renko M; Požgan U; Majera D; Turk D
FEBS J; 2010 Oct; 277(20):4338-45. PubMed ID: 20860624
[TBL] [Abstract][Full Text] [Related]
13. SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Singh M
Bioorg Med Chem; 2014 Aug; 22(15):4233-45. PubMed ID: 24913985
[TBL] [Abstract][Full Text] [Related]
14. Isoforms of Cathepsin B1 in Neurotropic Schistosomula of
Dvořáková H; Leontovyč R; Macháček T; O'Donoghue AJ; Šedo O; Zdráhal Z; Craik CS; Caffrey CR; Horák P; Mikeš L
Front Cell Infect Microbiol; 2020; 10():66. PubMed ID: 32175287
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer's Disease: Computational Refining and Biochemical Evaluation.
Chitranshi N; Kumar A; Sheriff S; Gupta V; Godinez A; Saks D; Sarkar S; Shen T; Mirzaei M; Basavarajappa D; Abyadeh M; Singh SK; Dua K; Zhang KYJ; Graham SL; Gupta V
Cells; 2021 Jul; 10(8):. PubMed ID: 34440715
[TBL] [Abstract][Full Text] [Related]
16. Human cathepsin X: A cysteine protease with unique carboxypeptidase activity.
Nägler DK; Zhang R; Tam W; Sulea T; Purisima EO; Ménard R
Biochemistry; 1999 Sep; 38(39):12648-54. PubMed ID: 10504234
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
18. Natural biflavones as novel inhibitors of cathepsin B and K.
Zeng GZ; Pan XL; Tan NH; Xiong J; Zhang YM
Eur J Med Chem; 2006 Nov; 41(11):1247-52. PubMed ID: 16828525
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations of bovine cathepsin B and its complex with CA074.
Yamamoto A; Tomoo K; Miyagawa H; Takaoka Y; Sumiya S; Kitamura K; Ishida T
Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):480-5. PubMed ID: 10783065
[TBL] [Abstract][Full Text] [Related]
20. Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110.
Pavlova A; Krupa JC; Mort JS; Abrahamson M; Björk I
FEBS Lett; 2000 Dec; 487(2):156-60. PubMed ID: 11150500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
